E. David Crawford, MD, Professor of Surgery and Radiation and Oncology Head, Urologic Oncology at the University of Colorado Health Sciences Center in Denver, Colorado, presents a lecture on the use of targeted therapy for the treatment of prostate cancer.

• Satisfaction And Regret After Radical Prostatectomy Procedures Studied

  (Thu, 28 Aug 2008 01:00:00 PDT)

  Studies have shown that approximately 16% of patients with localised prostate cancer regret their treatment choice. European Urology , the official journal of the European Association of Urology, will be publishing an article by J.W. Moul et al.

• Drug Designed To Lower Uric Acid Levels May Be Useful For Hypertension

  (Wed, 27 Aug 2008 03:00:00 PDT)

  According to a report published in the August 27 issue of JAMA, a drug that lowers uric acid levels, allopurinol, also seems to lower blood pressure in adolescents with newly diagnosed hypertension (high blood pressure). Hyperuricemia - a condition characterized by higher than normal blood levels of uric acid (a chemical found in urine and blood that results from normal bodily processes) - is commonly associated with hypertension.

• Robotic Kidney Removal Performed In Michigan

  (Wed, 27 Aug 2008 03:00:00 PDT)

  A diseased kidney has been surgically extracted using a minimally invasive technique that utilizes 3D robotics, at the Henry Ford Hospital, the first surgery of its kind in Michigan. About 55,000 people are diagnosed with kidney cancer every year. Treatment options, most commonly, involve open surgery with an incision approximately one foot (300 mm) long. Sometimes it is necessary to remove a rib and divert muscle in order to remove the kidney.

• Large Studies Needed To Further Confirm Prostate Cancer Drug Abiraterone

  (Wed, 27 Aug 2008 01:00:00 PDT)

  Larger trials are needed to further examine and confirm the early findings on the experimental drug abiraterone acetate (CB7630). Researcher Dr. Johann de Bono, from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust in the UK, who led two ongoing clinical trials of CB7630, said larger studies are necessary to find out the efficacy of the drug.

• Drug Discovery By University Of Miami Experts Will Lead To Better Treatments For Kidney Disease

  (Wed, 27 Aug 2008 01:00:00 PDT)

  Nephrology physician-scientists at the University of Miami Miller School of Medicine have discovered a critical pathway of a commonly used immunosuppressant drug, cyclosporine. The finding, made by Peter Mundel, M.D., professor and director of the Miami Institute of Renal Medicine, Christian Faul, Ph.D., assistant professor of medicine in the Division of Nephrology and Hypertension, and Jochen Reiser, M.D., Ph.D.